Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 257

1.

Vaccination in paediatric patients with auto-immune rheumatic diseases: a systemic literature review for the European League against Rheumatism evidence-based recommendations.

Heijstek MW, Ott de Bruin LM, Borrow R, van der Klis F, Koné-Paut I, Fasth A, Minden K, Ravelli A, Abinun M, Pileggi G, Borte M, Bijl M, Wulffraat NM.

Autoimmun Rev. 2011 Dec;11(2):112-22. doi: 10.1016/j.autrev.2011.08.010. Epub 2011 Aug 28. Review.

PMID:
21896342
2.

Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.

Nolan T, McIntyre P, Roberton D, Descamps D.

Vaccine. 2002 Dec 13;21(3-4):281-9.

PMID:
12450703
3.

Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.

Nolan T, Bernstein DI, Block SL, Hilty M, Keyserling HL, Marchant C, Marshall H, Richmond P, Yogev R, Cordova J, Cho I, Mendelman PM; LAIV Study Group..

Pediatrics. 2008 Mar;121(3):508-16. doi: 10.1542/peds.2007-1064.

PMID:
18310199
4.

Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.

Parment PA, Svahn A, Rudén U, Bråkenhielm G, Storsaeter J, Akesson L, Linde A.

Scand J Infect Dis. 2003;35(10):736-42.

PMID:
14606613
5.

Efficacy and safety of measles, mumps, rubella and varicella live viral vaccines in transplant recipients receiving immunosuppressive drugs.

Danerseau AM, Robinson JL.

World J Pediatr. 2008 Nov;4(4):254-8. doi: 10.1007/s12519-008-0047-1. Epub 2008 Dec 23. Review.

PMID:
19104888
6.

Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad(®)) in infants from 9 months of age.

Vesikari T, Becker T, Gajdos V, Fiquet A, Thomas S, Richard P, Baudin M.

Vaccine. 2012 Apr 26;30(20):3082-9. doi: 10.1016/j.vaccine.2012.02.062. Epub 2012 Mar 7.

PMID:
22406278
7.

Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Perez EE, Bokszczanin A, McDonald-McGinn D, Zackai EH, Sullivan KE.

Pediatrics. 2003 Oct;112(4):e325.

PMID:
14523220
8.

Varicella vaccines and measles, mumps, rubella, and varicella vaccine.

Bricks LF, Sato HK, Oselka GW.

J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S101-8. Review.

9.

Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.

Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, Soemantri P, Walther U, Macholdt U, Douha M, Pierson P, Willems P.

Pediatr Infect Dis J. 2008 Aug;27(8):724-30. doi: 10.1097/INF.0b013e318170bb22. Erratum in: Pediatr Infect Dis J. 2013 Apr;32(4):e163.

PMID:
18600190
10.

Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients.

Kawano Y, Suzuki M, Kawada J, Kimura H, Kamei H, Ohnishi Y, Ono Y, Uchida H, Ogura Y, Ito Y.

Vaccine. 2015 Mar 17;33(12):1440-5. doi: 10.1016/j.vaccine.2015.01.075. Epub 2015 Feb 7.

PMID:
25665961
11.

The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.

Lieberman JM, Williams WR, Miller JM, Black S, Shinefield H, Henderson F, Marchant CD, Werzberger A, Halperin S, Hartzel J, Klopfer S, Schödel F, Kuter BJ; Consistency Lot Study Group for ProQuad..

Pediatr Infect Dis J. 2006 Jul;25(7):615-22.

PMID:
16804432
12.

Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials.

Leung JH, Hirai HW, Tsoi KK.

Expert Rev Vaccines. 2015;14(8):1149-57. doi: 10.1586/14760584.2015.1057572. Epub 2015 Jun 16.

PMID:
26081133
13.

Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.

Shinefield HR, Black S, Kuter BJ.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S152-5. doi: 10.1086/522126.

PMID:
18419390
14.

A combination vaccine against measles, mumps, rubella and varicella.

Knuf M, Faber J, Barth I, Habermehl P.

Drugs Today (Barc). 2008 Apr;44(4):279-92. Review.

PMID:
18536786
15.

Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infants.

Yerkovich ST, Rowe J, Richmond P, Suriyaarachchi D, Heaton T, Hollams E, Ladyman C, Serralha M, Sadowska A, Loh R, Wesselingh SL, Sly PD, Holt PG.

Vaccine. 2007 Feb 26;25(10):1764-70. Epub 2006 Nov 27.

PMID:
17224218
16.

[Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox].

Buxbaum S, Doerr HW, Allwinn R.

Dtsch Med Wochenschr. 2001 Nov 16;126(46):1289-93. German.

PMID:
11709730
17.

Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children.

Shinefield HR, Black SB, Staehle BO, Matthews H, Adelman T, Ensor K, Li S, Chan I, Heyse J, Waters M, Chan CY, Vessey SJ, Kaplan KM, Kuter BJ; Kaiser Permanente Medical Team for Varivax..

Pediatr Infect Dis J. 2002 Jun;21(6):555-61.

PMID:
12182381
18.

EULAR recommendations for vaccination in paediatric patients with rheumatic diseases.

Heijstek MW, Ott de Bruin LM, Bijl M, Borrow R, van der Klis F, Koné-Paut I, Fasth A, Minden K, Ravelli A, Abinun M, Pileggi GS, Borte M, Wulffraat NM; EULAR..

Ann Rheum Dis. 2011 Oct;70(10):1704-12. doi: 10.1136/ard.2011.150193. Epub 2011 Aug 3.

PMID:
21813547
19.
20.

Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.

Ljungman P, Fridell E, Lönnqvist B, Bolme P, Böttiger M, Gahrton G, Linde A, Ringdén O, Wahren B.

J Infect Dis. 1989 Apr;159(4):610-5.

PMID:
2647859

Supplemental Content

Support Center